JPX : 2395.T

Shin Nippon Biomedical Laboratories, Ltd.

$1237 JPY

-$11 (-0.88%)

Volume
0
Average Volume
269.35K
Market Capitalization
$51.5B
P/E Ratio
11.28
Dividend Yield
4.04%
Price Target
Year High
$2005.00
Year Low
$1067.00
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.09
Company Overview

JPX

Ryoichi Nagata

Medical - Diagnostics & Research

Healthcare

2395.T

1522

JP

JPY

https://www.snbl.co.jp

81 3 5565 5001

N/A

N/A

Liquidity Metrics

0.96

1.09

0.71

0.47

0.00

Sales & Valuation

$32.52B

1.58

1.19

0.00

0.00

Profitability

$109.69

$4.57B

14.04%

19.21%

10.79%

4.35%

P/E Metrics

11.28

-1.55

-1.55

Analyst Price Target & Rating

Neutral

3/5

0 Analysts

%

Financial Health Scores

1.30

3/9

$3.66B

$105.06B

$61.57B

$4.17B

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Ichiro Nagata Sr. Executive VP, COO, Head of CRO Business, Head of Hospitality Business & Director
Hideshi Tsusaki Executive MD, Director, Head of Tech. Inf., Overseas Sales, NHP ARC & Global Business Dev.
Satoshi Matsumoto Managing Executive Officer & GM of Fisheries Division
Shu-Ichi Kanazashi Managing Executive Officer, CMO and General Manager of TR Business Division
Kyomi Nagatoshi Senior Managing Executive Officer, Head of General Affairs & Human Resources and Director
Shinji Nitanda Senior MD of Corporate Development & Corporate Tax Administration and Director
Fumihiko Makino Senior Executive Officer, Financial Controller and GM of Finance & Accounting
Ken Takanashi Executive Vice President of Group Corporate Management & Global Business & Director
Ryoichi Nagata President, Chairman, Chief Executive Officer, Group Chief Financial Officer, Fisheries Business Officer & Chief Health Officer
Terumasa Hirai Managing Executive Officer & President and Representative Director of SNBL Ina Research Center
Toshiyuki Iwata Managing Executive Officer, R/PR Division Manager & Sustainability Officer
Poll Results

No votes yet today — be the first to share your view!

About Shin Nippon Biomedical Laboratories, Ltd. (JPX:2395.T) Stock

Shin Nippon Biomedical Laboratories, Ltd. operates as a global contract research organization (CRO), delivering comprehensive drug discovery and development services both in Japan and internationally. Its preclinical offerings encompass a wide array of laboratory services, including regulatory-compliant good laboratory practice (GLP) inspections. These studies cover general and specialized toxicity assessments, detailed pathological examinations, pharmacokinetic (PK) and pharmacodynamic (PD) analysis for biopharmaceuticals, immunotoxicity testing, and antibody production. The company also conducts investigations into reproductive and developmental toxicity, pharmacological mechanisms, and efficacy, alongside providing various imaging services. Furthermore, the organization specializes in d ... eveloping and validating analytical methodologies, analyzing biological specimens, and determining pharmacokinetic parameters. It also conducts studies on absorption, distribution, metabolism, and excretion (ADME), often utilizing radioisotope-labeled compounds. Beyond preclinical and analytical work, it extends its expertise to clinical trial support through site management organization (SMO) services and broader clinical contract research organization (CRO) support. Its translational research division focuses on advancing novel medical solutions, such as the development of nasal drug delivery systems, nucleic acid-based adjuvants, and regenerative medicine therapies. Established in 1957, Shin Nippon Biomedical Laboratories, Ltd. maintains its headquarters in Tokyo, Japan.

Frequently Asked Questions

What is the current Shin Nippon Biomedical Laboratories, Ltd. (2395.T) stock price?

Shin Nippon Biomedical Laboratories, Ltd.(JPX:2395.T) stock price is $1237 in the last trading session. During the trading session, 2395.T stock reached the peak price of $2005 while $1067 was the lowest point it dropped to. The percentage change in 2395.T stock occurred in the recent session was --0.88% while the dollar amount for the price change in 2395.T stock was -$11.

2395.T's industry and sector of operation?

The JPX listed 2395.T is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.

Who are the executives of 2395.T?

Ichiro Nagata | Sr. Executive VP, COO, Head of CRO Business, Head of Hospitality Business & Director
Hideshi Tsusaki | Executive MD, Director, Head of Tech. Inf., Overseas Sales, NHP ARC & Global Business Dev.
Satoshi Matsumoto | Managing Executive Officer & GM of Fisheries Division
Shu-Ichi Kanazashi | Managing Executive Officer, CMO and General Manager of TR Business Division
Kyomi Nagatoshi | Senior Managing Executive Officer, Head of General Affairs & Human Resources and Director

How many employees does 2395.T have?

Number of 2395.T employees currently stands at 1522. 2395.T operates from 2438 Miyanoura-cho, Kagoshima, 891-1394, JP.

Link for 2395.T official website?

Official Website of 2395.T is: https://www.snbl.co.jp

How do I contact 2395.T?

2395.T could be contacted at phone #81 3 5565 5001 and can also be accessed through its website. 2395.T operates from 2438 Miyanoura-cho, Kagoshima, 891-1394, JP.

How many shares of 2395.T are traded daily?

The average number of 2395.T shares traded daily for last 3 months was 269.35K.

What is the market cap of 2395.T currently?

The market value of 2395.T currently stands at $51.5B with its latest stock price at $1237